Medicare Enrolled

Dr. Julianne Oboyle, MD

Neurology · Honesdale, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
600 MAPLE AVE, Honesdale, PA 18431
5702538635
In practice since 2005 (20 years)
NPI: 1750376182 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oboyle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oboyle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Oboyle

Dr. Julianne Oboyle is a neurology specialist in Honesdale, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Oboyle performed 184 Medicare services across 170 unique beneficiaries.

Between the years covered by Open Payments, Dr. Oboyle received a total of $8,660 from 50 pharmaceutical and/or device companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Oboyle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 184 Medicare services $8,660 industry payments

Medicare Practice Summary

Medicare Utilization ↗
184
Medicare services
Bottom 30% in PA for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
170
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
73 $63 $165
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
67 $31 $100
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
29 $100 $226
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $133 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,660
Total received (2018-2024)
Avg $1,237/year across 7 years
Top 23% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
504
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,660 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,365
2023
$1,560
2022
$1,467
2021
$1,358
2020
$667
2019
$818
2018
$425

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$251
Novartis Pharmaceuticals Corporation
$229
UCB, Inc.
$182
Alexion Pharmaceuticals, Inc.
$175
PFIZER INC.
$169
Kyowa Kirin, Inc.
$132
E.R. Squibb & Sons, L.L.C.
$125
Eisai Inc.
$108
Amgen Inc.
$95
EMD Serono, Inc.
$89
MDD US Operations, LLC
$89
Lundbeck LLC
$87
TG Therapeutics, Inc.
$73
SK Life Science, Inc.
$67
Celgene Corporation
$62
ARGENX US, INC.
$62
Otsuka America Pharmaceutical, Inc.
$55
Genentech USA, Inc.
$52
Lilly USA, LLC
$47
Biogen, Inc.
$44
ACADIA Pharmaceuticals Inc
$34
Olympus America Inc.
$34
Neurocrine Biosciences, Inc.
$32
Davol Inc.
$22
W. L. Gore & Associates, Inc.
$19
Grifols USA, LLC
$16
CATALYST PHARMACEUTICALS, INC.
$16
Top 3 companies account for 28.0% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$1,189
Novartis Pharmaceuticals Corporation
$1,062
Alexion Pharmaceuticals, Inc.
$1,017
ABBVIE INC.
$452
EMD Serono, Inc.
$414
Kyowa Kirin, Inc.
$362
Janssen Pharmaceuticals, Inc
$324
Amgen Inc.
$313
PFIZER INC.
$303
Neurocrine Biosciences, Inc.
$228
Eisai Inc.
$224
E.R. Squibb & Sons, L.L.C.
$214
Lundbeck LLC
$208
Supernus Pharmaceuticals, Inc.
$186
Lilly USA, LLC
$183
UCB, Inc.
$182
Biohaven Pharmaceuticals, Inc.
$162
Celgene Corporation
$142
Teva Pharmaceuticals USA, Inc.
$141
LivaNova USA, Inc.
$134
ARGENX US, INC.
$105
Genentech USA, Inc.
$92
Avion Pharmaceuticals
$90
MDD US Operations, LLC
$89
SK Life Science, Inc.
$82
TG Therapeutics, Inc.
$73
Biohaven Pharmaceutical Holding Company Ltd.
$59
Otsuka America Pharmaceutical, Inc.
$55
ACADIA Pharmaceuticals Inc
$47
AbbVie Inc.
$44
KCI USA, Inc
$39
EISAI INC.
$39
Olympus America Inc.
$34
CATALYST PHARMACEUTICALS, INC.
$33
Sunovion Pharmaceuticals Inc.
$28
Adamas Pharmaceuticals, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Avanir Pharmaceuticals, Inc.
$26
GENZYME CORPORATION
$23
Myriad Genetic Laboratories, Inc.
$23
Davol Inc.
$22
Allergan Inc.
$21
Horizon Therapeutics plc
$21
PORTOLA PHARMACEUTICALS, INC.
$20
W. L. Gore & Associates, Inc.
$19
CONMED Corporation
$19
IMPEL PHARMACEUTICALS INC.
$18
Baudax Bio Inc.
$17
Grifols USA, LLC
$16
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
ACTIVAC · ADUHELM · AIMOVIG · AIRSEAL · AJOVY · AMYVID · ANDEXXA · ANJESO · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · BRIUMVI · Briviact · COMIRNATY · COPAXONE · DALVANCE · Dhivy · EMGALITY · ENDOEYE FLEX DEFLECTABLE VIDEOSCOPE · FIRDAPSE · GATTEX · GILENYA · GOCOVRI · GORE SYNECOR Biomaterial · Gamunex-C · Gocovri · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OLYMPUS · ONGENTYS · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · PLEGRIDY · PRADAXA · Phasix Mesh · Ponvory · QALSODY · QULIPTA · REXULTI · Rystiggo · SOLIRIS · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VAC VERAFLO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · XCOPRI · ZEPOSIA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Honesdale?
Compare neurologists in the Honesdale area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
7
Per 100K population
13.7
County median income
$62,182
Nearest hospital
WAYNE MEMORIAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Oboyle is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Oboyle experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Oboyle performed 73 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oboyle receive payments from pharmaceutical companies?
Yes. Dr. Oboyle received a total of $8,660 from 50 companies across 504 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oboyle's costs compare to other neurologists in Honesdale?
Dr. Oboyle's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oboyle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →